These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11907741)

  • 1. Intraarterial lidocaine administration for relief of pain resulting from transarterial chemoembolization of hepatocellular carcinoma: its effectiveness and optimal timing of administration.
    Lee SH; Hahn ST; Park SH
    Cardiovasc Intervent Radiol; 2001; 24(6):368-71. PubMed ID: 11907741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoembolization for hepatocellular carcinoma: effect of intraarterial lidocaine in peri- and post-procedural pain and hospitalization.
    Romano M; Giojelli A; Tamburrini O; Salvatore M
    Radiol Med; 2003 Apr; 105(4):350-5. PubMed ID: 12835628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.
    Zhou WP; Lai EC; Li AJ; Fu SY; Zhou JP; Pan ZY; Lau WY; Wu MC
    Ann Surg; 2009 Feb; 249(2):195-202. PubMed ID: 19212170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and risk factors for acute renal failure in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: a prospective study.
    Huo TI; Wu JC; Lee PC; Chang FY; Lee SD
    Liver Int; 2004 Jun; 24(3):210-5. PubMed ID: 15189271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
    Park JW; Park KW; Cho SH; Park HS; Lee WJ; Lee DH; Kim CM
    Am J Gastroenterol; 2005 Oct; 100(10):2194-200. PubMed ID: 16181368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients.
    Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL
    Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transarterial chemoembolization with high dose iodized oil for the treatment of large hepatocellular carcinoma].
    Chen M; Li J; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):165-7. PubMed ID: 11783027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH; Choi MS; Choi YS; Kim DY; Lee JM; Paik SW; Lee JH; Koh KC; Yoo BC; Choi D; Rhee JC
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary loco-regional therapy for unresectable hepatocellular carcinoma: a prospective survey.
    Huo T; Huang YH; Wu JC; Chiang JH; Lee PC; Chang FY; Lee SD
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1301-8. PubMed ID: 15191512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors.
    Lu W; Li Y; He X; Chen Y
    Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.